Reperfusion therapy for acute myocardial infarction: Drugs or devices? is this the right question?

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cardiology

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/CLC.4960270502PMID 15188937PMCID PMC6653954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.

  2003cited by this paper
• A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.

  2003cited by this paper
• Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.

  2003cited by this paper
• Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.

  2003cited by this paper
• Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.

  2002cited by this paper
• Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.

  2002cited by this paper
• Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

  2002cited by this paper
• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes.

  2001cited by this paper
• Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

  2001cited by this paper
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

  2001cited by this paper
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

  2001cited by this paper
• Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.

  2000cited by this paper
• Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction.

  2000cited by this paper
• Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

  2000cited by this paper
• A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial

  1999cited by this paper
• Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.

  1999cited by this paper
• A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.

  1999cited by this paper
• Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction

  1999cited by this paper
• Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

  1999cited by this paper
• Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

  1998cited by this paper
• Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

  1996cited by this paper
• Illusion of Reperfusion Does Anyone Achieve Optimal Reperfusion During Acute Myocardial Infarction?

  1993cited by this paper
• Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

  1993cited by this paper

• Multivessel Percutaneous Coronary Intervention in Chinese Patients with Acute Myocardial Infarction and Simple Nonculprit Arteries

  2007cites this paper
• Reperfusion of myocardium does not necessarily equate with epicardial coronary artery blood flow

  2004cites this paper